Literature DB >> 2339798

The thermoregulatory threshold is inversely proportional to isoflurane concentration.

R Støen1, D I Sessler.   

Abstract

This study tested the hypothesis that the threshold for thermoregulatory vasoconstriction is lowered as isoflurane concentration increases, but the intensity of vasoconstriction, once triggered, is well preserved during isoflurane anesthesia. The thermoregulatory threshold was prospectively defined as the central temperature at which vasoconstriction occurred, and significant vasoconstriction was defined as a skin-surface temperature gradient (forearm-fingertip) greater than or equal to 4 degrees C. The threshold for thermoregulatory vasoconstriction and the intensity of vasoconstriction, measured as maximum skin-temperature gradient, was determined in six unpremedicated patients electively donating a kidney during isoflurane anesthesia, and in four healthy, awake volunteers. All anesthetized patients were deliberately cooled and became hypothermic. Vasoconstriction occurred in five of six at central temperatures between 35.3 and 32.4 degrees C, at end-tidal isoflurane concentrations between 0.74 and 1.65%. The patient who did not vasoconstrict received the highest isoflurane concentration (approximately 2.5%) and reached a central temperature of 31 degrees C. Unanesthetized volunteers also were exposed to cold and each vasoconstricted at a temperature near 37 degrees C. The threshold for thermoregulatory cutaneous vasoconstriction was inversely correlated with anesthetic dose, the thermoregulatory threshold decreasing approximately 3 degrees C/% isoflurane concentration. There were no statistically significant differences between maximum skin-surface temperature gradients in awake volunteers and patients given isoflurane, or between any of the groups when patients from previous studies given halothane or nitrous oxide/fentanyl anesthesia were included in the comparison. These data indicate that the intensity of vasoconstriction, once triggered, is similar during several different types of anesthesia.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2339798     DOI: 10.1097/00000542-199005000-00009

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  8 in total

1.  Anesthetic management for a patient with oculocerebrorenal (Lowe's) syndrome.

Authors:  Hisao Komatsu; Masatomo Sakakibara; Yutaka Yoshimura; Hiroyuki Kinoshita; Satoshi Yokono; Kenji Ogli
Journal:  J Anesth       Date:  1994-03       Impact factor: 2.078

2.  Temperature control and the role of supplemental oxygen.

Authors:  Vance Y Sohn; Scott R Steele
Journal:  Clin Colon Rectal Surg       Date:  2009-02

3.  Cross-sectional area of the murine aorta linearly increases with increasing core body temperature.

Authors:  A Colleen Crouch; Adam B Manders; Amos A Cao; Ulrich M Scheven; Joan M Greve
Journal:  Int J Hyperthermia       Date:  2017-11-06       Impact factor: 3.914

4.  Effects of PEEP on the thermoregulatory responses during TIVA in patients undergoing tympanoplasty.

Authors:  Tae-Hun An; Jung-Woo Yang
Journal:  Korean J Anesthesiol       Date:  2011-10-22

5.  A comparison of the temperature difference according to the placement of a nasopharyngeal temperature probe.

Authors:  Hyungsun Lim; Boram Kim; Dong-Chan Kim; Sang-Kyi Lee; Seonghoon Ko
Journal:  Korean J Anesthesiol       Date:  2016-06-22

6.  Cross-sectional areas of deep/core veins are smaller at lower core body temperatures.

Authors:  Anna Colleen Crouch; Ulrich M Scheven; Joan M Greve
Journal:  Physiol Rep       Date:  2018-08

7.  Nitrous oxide improves cardiovascular, respiratory, and thermal stability during prolonged isoflurane anesthesia in juvenile guinea pigs.

Authors:  Ryan P Sixtus; Clint Gray; Mary J Berry; Rebecca M Dyson
Journal:  Pharmacol Res Perspect       Date:  2021-02

Review 8.  Mouse Anesthesia: The Art and Science.

Authors:  Kaela L Navarro; Monika Huss; Jennifer C Smith; Patrick Sharp; James O Marx; Cholawat Pacharinsak
Journal:  ILAR J       Date:  2021-12-31       Impact factor: 1.521

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.